TFX Stock Analysis: Buy, Sell, or Hold?

TFX - Teleflex Incorporated

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$130.28
0.24 (0.18%) ▲
5d: -1.06%
30d: +3.12%
90d: +24.62%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026 0d
Smart Money Distribution

TFX is up 5.5% this week, but smart money is buying puts. Top strike: $115 2026-06-18 with 4 OI. Put ratio: 100% View Scanner →

Strength: 7.8/10

Get Alerted When TFX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: TFX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$191.45
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$118.88
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.4x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: TFX is currently trading at $130.28, which is considered fair relative to its 30-day fair value range of $120.65 to $133.88. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.4) compared to its historical average (9.4). At these levels, the market is pricing in 9.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, TFX is in a uptrend. Immediate support is located at $118.52, while resistance sits at $136.30.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $143.67 (+10.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $120.65 - $133.88
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 75.0%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($143.67)
  • NEUTRAL: Trading at premium valuation - market expects 9.8% growth which is achievable

Trading Range Analysis

30-Day Trading Range $120.65 - $133.88
Current vs Trading Range FAIR
Expected Move (7 Days) ±$7.90 (6.1%)

Support & Resistance Levels

Support Level $118.52
Resistance Level $136.30
Current Trend Uptrend
Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 12.43
Wall Street Target $143.67 (+10.5%)
Revenue Growth (YoY) 32.3%
Earnings Growth (YoY) 64.1%
Profit Margin -47.4%
Valuation Premium vs History +9.8% premium
PE vs Historical 12.4 vs 9.4 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +9.8% (market-implied from PE analysis)
1-Year Target $142.78 (+10%)
2-Year Target $156.78 (+21%)
3-Year Target $172.14 (+32%)
3-Yr Target (if PE normalizes) (PE: 12→9) PE COMPRESSION $130.14 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.0, Growth: 55.4%) $777.99 (+498%)
Base: (SPY PE: 12.4, Growth: 55.4%) $438.88 (+238%)
Bear: (PE: 9.4, Growth: 55.4%) $331.81 (+155%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Forward PE: 19.88 | Forward EPS (Implied): $6.54
Bull Case $157.02 (+21%)
Analyst growth 15.0%, PE expands to 20.9
Base Case $130.04 (0%)
Market implied 0.0%, PE stable at 19.9
Bear Case $99.48 (-24%)
Severe decline -15.0%, PE contracts to 17.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 14, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TFX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$577 58 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$88 53 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$180 52 HOLD
RMD
ResMed Inc
BUY
19 analysts
$271 59 HOLD
COO
The Cooper Companies, Inc
BUY
19 analysts
$91 64 BUY

Advanced TFX Option Strategies

Professional options setups generated by AI based on today's TFX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TFX

TFX Technical Chart TFX Price Prediction TFX Earnings Date TFX Investment Advisor TFX Fair Price Analyzer TFX Options Advisor TFX Options Chain TFX Options Analysis TFX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals